Literature DB >> 21746966

Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.

Eva-Maria Weiss1, Angelika Schmidt, Diana Vobis, Natalio Garbi, Katharina Lahl, Christian T Mayer, Tim Sparwasser, Andreas Ludwig, Elisabeth Suri-Payer, Nina Oberle, Peter H Krammer.   

Abstract

CD4(+)CD25(++)Foxp3(+) regulatory T cells (Tregs) control self-reactive cells to maintain peripheral tolerance. Treg homeostasis has to be controlled tightly to ensure balanced Treg-mediated suppression. One mechanism that regulates the CD4(+) T cell pool is activation-induced cell death (AICD). This is mimicked in vitro by TCR restimulation-induced expression of the death ligand CD95L (FasL/APO-1L/CD178) in expanded T cells. These cells express the death receptor CD95 (Fas/APO-1), and binding of CD95L to CD95 results in AICD. In contrast, Tregs do not undergo AICD upon TCR (re)stimulation in vitro despite a functional CD95 cell death pathway. In this study, we show that human and murine Tregs express low levels of CD95L upon stimulation. Knockdown of the transcriptional repressor Foxp3 partially rescues CD95L expression and AICD in human Tregs. Moreover, upon stimulation Foxp3-mutant Tregs from Scurfy mice express CD95L similar to conventional T cells. We further addressed whether exogenous CD95 stimulation provides a mechanism of Treg homeostatic control in vivo in mice. Triggering of CD95 reduced Treg numbers systemically as reflected by in vivo imaging and decreased GFP(+) Treg numbers ex vivo. Our study reveals that Foxp3 negatively regulates CD95L expression in Tregs and demonstrates that Tregs are susceptible to homeostatic control by CD95 stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746966     DOI: 10.4049/jimmunol.1002321

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Kazuyuki Murase; Haesook T Kim; O R Gregory Bascug; Yutaka Kawano; Jeremy Ryan; Ken-ichi Matsuoka; Matthew S Davids; John Koreth; Vincent T Ho; Corey Cutler; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Anthony Letai; Jerome Ritz
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

3.  Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.

Authors:  Angélique Biancotto; Pradeep K Dagur; John C Fuchs; Adrian Wiestner; C Bruce Bagwell; J Philip McCoy
Journal:  Mod Pathol       Date:  2011-11-18       Impact factor: 7.842

4.  A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.

Authors:  Ling-Hui Hsu; Kun-Po Li; Kuan-Hua Chu; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

Review 5.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

Review 6.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

7.  FOXP3 renders activated human regulatory T cells resistant to restimulation-induced cell death by suppressing SAP expression.

Authors:  Gil Katz; Kelsey Voss; Toria F Yan; Yong Chan Kim; Robert L Kortum; David W Scott; Andrew L Snow
Journal:  Cell Immunol       Date:  2018-02-12       Impact factor: 4.868

8.  Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection.

Authors:  Simon Metenou; Yaya I Coulibaly; Daniel Sturdevant; Housseini Dolo; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Kishore Kanakabandi; Stephen F Porcella; Amy D Klion; Thomas B Nutman
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

9.  Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.

Authors:  Shahram Kordasti; Benedetta Costantini; Thomas Seidl; Pilar Perez Abellan; Marc Martinez Llordella; Donal McLornan; Kirsten E Diggins; Austin Kulasekararaj; Cinzia Benfatto; Xingmin Feng; Alexander Smith; Syed A Mian; Rossella Melchiotti; Emanuele de Rinaldis; Richard Ellis; Nedyalko Petrov; Giovanni A M Povoleri; Sun Sook Chung; N Shaun B Thomas; Farzin Farzaneh; Jonathan M Irish; Susanne Heck; Neal S Young; Judith C W Marsh; Ghulam J Mufti
Journal:  Blood       Date:  2016-06-08       Impact factor: 22.113

10.  Transforming growth factor-β1 sustains the survival of Foxp3(+) regulatory cells during late phase of oropharyngeal candidiasis infection.

Authors:  N Bhaskaran; C Quigley; A Weinberg; A Huang; D Popkin; P Pandiyan
Journal:  Mucosal Immunol       Date:  2015-11-04       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.